Institutional Best Practices for Treating Schizophrenia

Joe Avelino, RN, BSN, MHSA, CPHQ; Rahn Bailey, MD, DFAPA; and Henry Nasrallah, MD discuss the benefits of long-acting injectables in the management of schizophrenia and system protocols that are in place for the use of long-acting injectables in an institutional setting.